6 High-Yield Stocks Where the Market May Be Warning of a Dividend Cut
A fat dividend yield can mean a generous payout or a stock the market has already written off, and right now six familiar names are flashing signals that suggest the difference matters more than ever.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Income investors have a real alternative right now. The 10-year Treasury yielded 5.26% as of September 29, 2026, so any stock paying more has to earn that extra income with real cash. A headline yield only holds up if the company can keep funding it. Often a fat yield is the market signaling trouble the payout has not yet admitted.
Here is the test: a dividend is sustainable when the right earnings measure covers it, free cash flow pays for it after capital spending, and debt is not doing the heavy lifting. (We counted seven red flags that a fat yield is about to be cut in a free dividend trap guide, which is a useful checklist to run against the names below.)
Kraft Heinz (KHC): A Yield Built on a Falling Price
Kraft Heinz (NASDAQ:KHC | KHC Price Prediction) pays $1.6 per share a year, a dividend yield of 6.79%. The payout has not grown. The quarterly dividend has sat at $0.4 since 2020, down from $0.625 in 2018. Shares at $22.77 are down 59.24% over ten years. That marks a price-driven yield.
Earnings coverage is the second problem. A $7.4B impairment left trailing diluted EPS at -$2.88. Adjusted EPS guidance of $2.03 to $2.09 still covers the dividend, but organic sales are guided -0.5% to -2.0% and brand spending is rising $100M to ~$700M. Cash flow holds up for now: Q2 operating cash flow of $1.082B against capex of $189M and dividends of $475M. Hitting the ~110% FCF conversion target is what keeps this payout safe.
Verizon (VZ): Leverage Is Creeping Higher
Verizon (NYSE:VZ) yields 6.08% on a forward dividend of $2.83. Share price has worked in Verizon’s favor: shares are up 18.28% year to date, and the quarterly payout rose to $0.7075 from $0.69.
The warning sign is what the company owes. Total unsecured debt stands at $136.5B, and net unsecured debt to adjusted EBITDA rose to 2.5x from 2.2x at year-end 2025. Revenue slipped 0.7% and GAAP net income fell 22.9%, while a buyback target of up to $4.5B competes for the same cash. Cash flow offers support: Q2 free cash flow of $6.43B rose 27.1%.
Altria (MO): Raising the Payout on a Shrinking Base
Altria (NYSE:MO) just lifted its quarterly dividend to $1.11 from $1.06, a forward $4.44 on a $67.44 stock. Shares are up 22.63% year to date, so this yield reflects payout policy.
The danger is holding a dividend through structural stress. Stockholders’ equity is -$3.21B, cash fell 25% to $3.53B, and domestic cigarette volume dropped 5%. Marlboro share slipped to 39.7% and on! pouches lost 4.2 points. Adjusted EPS guidance of $5.56 to $5.72 covers the payout, but pricing power has to keep outpacing volume loss.
AT&T (T): A Cut Already on the Record
AT&T (NYSE:T) pays $1.11 a year, a yield near 5%, with shares down 9.29% over the past year. The quarterly dividend was $0.52 until it fell to $0.2775 in 2022, flat ever since.
Here the pressure is cash allocation plus debt. Q2 free cash flow of $4.67B fell 4.0%, while the quarter funded $1.976B in dividends and $2.194B in buybacks. Net debt to adjusted EBITDA is 2.68x, above the 2.5x target, and interest expense rose 13.8%. Buybacks give management a lever to pull before cutting the dividend, and FCF guidance of $18B+ supports the payout.
Pfizer (PFE): Free Cash Flow Trails the Dividend
Pfizer (NYSE:PFE) yields 5.99% on $1.72 a year, with shares down 13.48% over five years.
The sharpest warning is cash coverage: a free cash flow yield of 5.58% against a 6.01% dividend yield. Q2 operating cash flow was $835M against $2.451B in dividends, and trailing GAAP EPS of $0.76 sits below the payout. Net debt to EBITDA is 3.26. Adjusted EPS guidance of $2.80 to $3.00 covers it, and the chief executive said “even in the most stretched scenarios that we are running, we will be able to maintain our dividend.”
Medical Properties Trust: Expensive Debt Eats the Cushion
Medical Properties Trust pays $0.09 quarterly, a yield of roughly 7% to 8% on a stock that last filed at $4.70, after prior cuts. As a REIT, it should be judged on normalized FFO: $0.15 per share, a payout near 60%.
Debt is the threat. New secured notes carry a 9.25% coupon against a 5.37% weighted average rate, net debt to EBITDAre is 8.9x, and interest coverage is just 1.9x. Tenant HSA was paying 75% of agreed rent. Asset sales and no due dates until a roughly $600 million note in June 2028 buy time.
What to Watch Before the Next Declaration
Keep an eye on quarterly free cash flow against dividends paid, leverage ratios against stated targets, and whether buybacks decline first. When a cut comes, it usually pulls the share price down too, so the yield you locked in can cost principal. Yield by itself does not make a thesis.
Contact [email protected] for any questions or corrections.
Chris Lange is a financial and geopolitical writer with more than a decade of experience covering a myriad of topics. He has published thousands of articles for 24/7 Wall St., with past coverage focused heavily on stocks, IPOs, healthcare, defense, global affairs, and technology.
His work has been quoted, or referenced by a number of outlets including Business Insider, USA Today, Yahoo Finance, MSN, The Motley Fool, and many other publications. A graduate of Southwestern University, he studied business with a focus on investments and has previous experience in banking and startups.
When not reading or writing the news, he is following his passion for Lacrosse, playing chess, or building solar projects with his dad.
